Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes

G.S.D. Purvis, M. Collino, R.A. Loiola, A. Baragetti, F. Chiazza, M. Brovelli, M.H. Sheikh, D. Collotta, A. Cento, R. Mastrocola, M. Aragno, J.C. Cutrin, C. Reutelingsperger, L. Grigore, A.L. Catapano, M.M. Yaqoob, G.D. Norata, E. Solito, C. Thiemermann

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number571
Number of pages16
JournalFrontiers in Immunology
Volume10
DOIs
Publication statusPublished - 27 Mar 2019

Keywords

  • a1
  • annexin a1
  • cardiac dysfunction
  • glucocorticoids
  • hepatosteatosis
  • kinase inhibitor
  • mechanisms
  • metabolism
  • metformin
  • nephropathy
  • progression
  • protects
  • rho a
  • statins
  • type-2 diabetes
  • GLUCOCORTICOIDS
  • STATINS
  • Rho A
  • A1
  • Annexin A1
  • PROGRESSION
  • METFORMIN
  • CARDIAC DYSFUNCTION
  • MECHANISMS
  • KINASE INHIBITOR
  • NEPHROPATHY
  • PROTECTS

Cite this